Elements that can influence the price of this asset:

Analysis N°1

Firstly, we would of course carefully monitor all the financial publications and announcements of this company as well as reports on its income and profitability.You will find all these detailed figures directly on the website of the Canopy Growth Company which transparently communicates various information to its investors.

Analysis N°2

All the buyout, acquisition, partnership and merger operations implemented by the Canopy Growth Group will of course be important and represent significant indicators to follow.There again you will find these news and events on the company’s website.

Analysis N°3

We would also of course follow any changes in regulations concerning the legalisation of recreational cannabis which would open new markets to Canopy Growth and enable it to generate supplementary income.

Analysis N°4

Finally, as we explained earlier, we would monitor the growth in the market share of this group’s competitor Aurora Cannabis together with its announcements, publications, financial results and important events which could directly influence the share price of Canopy Growth.

--- Advertisement ---
Trade in Canopy Growth shares!
76.4% of retail investor accounts lose money when trading CFDs with this provider.

General presentation of the Canopy Growth Company:

The Canadian group Canopy Growth is a specialist in the production and sale of medical cannabis.This company in facts markets different products from the culture of medical cannabis such as oils and concentrates as well as capsules and hemp.

The products sold by Canopy Growth have the main objective of naturally treating chronic pain associated with certain illnesses, treating convulsions or muscular spasms and other health problems such as nausea or lack of appetite.

This company was created in 2009 at Smith Falls in Canada and is now a large scale business with a number of subsidiaries among which we find for example Canopy Health Innovations, Mettrum Health Corporation, BC Tweed Joint Venture, Spot Therapeutics, HEMPCA, Tokyo Smoke, Annabis Medical, Spectrum Cannabis Chile, Spectrum Chile, Tweed, Bedrocan Cannabis Corp, Daddy Can Lesotho PTY, Spectrum Cannabis Denmark, Prime1 Construction Services, Tweed Farms, Vert Medical, Canopy LATAM, MedCann Gmbh, Trees Producers Limited and Tweed Grasslands Cannabis Inc.Through all these subsidiaries Canopy Growth employs over 1,030 people around the world.

The Canopy Growth group is also known as being the first company in this activity sector in North America to have been introduced onto the stock markets.This group is in fact included in the S&P/TSX stock market index.

 

Know the competition to Canopy Growth shares:

The Canadian group Canopy Growth is undoubtedly one of the rarest companies of this size exercising activities in the therapeutic cannabis sector. However, it is not the only company to target this new market sector and the legalisation of this type of treatment is increasing in range progressively throughout the world.The competitors of Canopy Growth are few at present but it is important you know about them if you wish to speculate in this asset on the stock markets.

Recently, the medical cannabis market has experienced a major change as until recently Canopy Growth was the leader in this sector, followed by the Aurora Group, then CanniMed.However in January 2018 the Aurora Group completed the buyout of CanniMed creating a new company named Aurora Cannabis.It is currently this new company that is the largest therapeutic cannabis producer worldwide.

Tilray Inc.: This is another Canadian company that is currently achieving great success in the medical and therapeutic cannabis sectors and which is also developing a range of products manufactured from hemp. It is therefore recommended that you take this company into account when analysing the competitors of the Canopy Growth Company.

 

The strategic alliances implemented by the Canopy Growth group:

Over the last few years the Canopy Growth Company has heavily invested in the implementation of strategic partnerships with various companies in similar or complementary sectors.This has enabled the company to enlarge its field of activities as well as gain position in new markets and highly advantageous contracts.To better understand the benefits of this type of alliance we offer you the opportunity to learn about some of the more recent ones here together with their objectives.

 

The advantages and strong points of the Canopy Growth shares as stock market assets:

 

The disadvantages and weak points of Canopy Growth shares as stock market assets:

To summarise, even if the disadvantages of the Canopy Growth Company appear less numerous than the advantages it is still necessary for every serious investor to take them into account when completing analyses and not just launch a buying strategy without reflection.

Frequently Asked Questions

Where is the Canopy Growth share price quoted?

The Canopy Growth share price, like that of other securities in this sector of activity in Canada, is listed on the Toronto Stock Exchange or Toronto Stock Exchange also called TSX. This stock exchange is now the largest Canadian stock market and the second in North America just after the American NYSE. It is also the ninth in the world in terms of market capitalization. It is also a division of the TMX group specializing in share exchanges.

What are Canopy Growth's latest acquisitions?

Canopy Growth acquired Kiku Brands which operates the Tokyo Smoke brand in July 2018 for C $ 298 million. In April 2019, Canopy Growth also acquired the American company Acreage Holdings, which specializes in the production and distribution of cannabis, for $ 3.4 billion. Finally, in the same year, Canopy also acquired This Works for US $ 55 million in order to diversify into CBD beauty and sleep aid products.

What is the total market capitalization of the Canopy Growth group?

To date, in May 2020, the total market capitalization of the Canopy Growth group reached 10483 million Canadian dollars. It should also be noted that the group published for the year 2019 a turnover of 253 million Canadian dollars and a net profit of nearly 685 million Canadian dollars.

--- Advertisement ---
Trade in Canopy Growth shares!
76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.